Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention

Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk f...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 263; pp. 343 - 351
Main Authors Masoudkabir, Farzad, Sarrafzadegan, Nizal, Gotay, Carolyn, Ignaszewski, Andrew, Krahn, Andrew D., Davis, Margot K., Franco, Christopher, Mani, Arya
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.08.2017
Subjects
Online AccessGet full text
ISSN0021-9150
1879-1484
1879-1484
DOI10.1016/j.atherosclerosis.2017.06.001

Cover

Abstract Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. [Display omitted] •Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide.•CVD and cancer have common risk factors and shared genetics and molecular mechanisms that are central to their pathogenesis.•The shared pathways of CVD and cancer are potential targets for development of novel drugs for joint pharmacologic prevention of CVD and cancer.•A growing body of evidence supports a role for aspirin, statins, ACE inhibitors/ARBs, metformin, and TZDs in cancer prevention.•Both pharmacologic and non-pharmacologic preventive programs should be directed jointly at CVD and cancer.
AbstractList Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization’s joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
Abstract Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help to identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. [Display omitted] •Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide.•CVD and cancer have common risk factors and shared genetics and molecular mechanisms that are central to their pathogenesis.•The shared pathways of CVD and cancer are potential targets for development of novel drugs for joint pharmacologic prevention of CVD and cancer.•A growing body of evidence supports a role for aspirin, statins, ACE inhibitors/ARBs, metformin, and TZDs in cancer prevention.•Both pharmacologic and non-pharmacologic preventive programs should be directed jointly at CVD and cancer.
Author Mani, Arya
Masoudkabir, Farzad
Gotay, Carolyn
Franco, Christopher
Davis, Margot K.
Sarrafzadegan, Nizal
Ignaszewski, Andrew
Krahn, Andrew D.
AuthorAffiliation c School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
d Cancer Control Research Program, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
b Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
e Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
f Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
a Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
AuthorAffiliation_xml – name: c School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
– name: d Cancer Control Research Program, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
– name: a Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
– name: e Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
– name: b Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
– name: f Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
Author_xml – sequence: 1
  givenname: Farzad
  surname: Masoudkabir
  fullname: Masoudkabir, Farzad
  organization: Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Nizal
  surname: Sarrafzadegan
  fullname: Sarrafzadegan, Nizal
  email: nsarrafzadegan@gmail.com
  organization: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
– sequence: 3
  givenname: Carolyn
  surname: Gotay
  fullname: Gotay, Carolyn
  organization: School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 4
  givenname: Andrew
  surname: Ignaszewski
  fullname: Ignaszewski, Andrew
  organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 5
  givenname: Andrew D.
  surname: Krahn
  fullname: Krahn, Andrew D.
  organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 6
  givenname: Margot K.
  surname: Davis
  fullname: Davis, Margot K.
  organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 7
  givenname: Christopher
  surname: Franco
  fullname: Franco, Christopher
  organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 8
  givenname: Arya
  surname: Mani
  fullname: Mani, Arya
  organization: Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28624099$$D View this record in MEDLINE/PubMed
BookMark eNqVkt-LEzEQx4OceL3Tf0H2RfBla5Luj0RQkFJP4cAH9TmMk-w1NU3WZLdH_3uz9uzpgWBfMoGZfGbyne8FOfPBG0JeMDpnlDWvNnMY1iaGhG46bZpzyto5beaUskdkxkQrS1aJ6ozMKOWslKym5-QipQ2ltGqZeELOuWh4RaWcEb2EqG3YQcLRQSy0TQaSKcDrAsGjia-L1c5qk69FF2KR1hCNPtb1eZpb2KdfD_qc2wIGF24sFn00O-MHG_xT8rgDl8yzu3hJvr5ffVl-KK8_XX1cvrsusWHNUCJoJupOoO7qruMIpkOUQrdctAyrBuu6EjmC0LptJDQ157rmclGLSnd6sbgkbw_c0fewvwXnVB_tFuJeMaom-dRGPZBPTfIp2qgs3z2gH79tjcY8foR7SACr_s54u1Y3YacaTltZ8Qx4eQeI4cdo0qC2NqFxDrwJY1JMMsakEELm0ud_9jo2-b2bXLA8FGAeNEXTKbQDTHrm1tb995fePKCcKsnV4b3Ji9tZE1VCO7lB22hwUDrYU8U9ktBZbxHcd7M3aRPG6LM7FFOJK6o-T-6dzMvaBeXZ0Bmw-jfghEF-Au5NDsU
CitedBy_id crossref_primary_10_35366_95587
crossref_primary_10_1016_j_lfs_2023_122244
crossref_primary_10_2459_JCM_0000000000000701
crossref_primary_10_2139_ssrn_4046665
crossref_primary_10_1177_2047487319895415
crossref_primary_10_1200_OP_20_01053
crossref_primary_10_1016_j_medcli_2023_01_007
crossref_primary_10_1016_j_lpmfor_2023_10_020
crossref_primary_10_1016_j_medcle_2023_01_012
crossref_primary_10_1016_j_jaccao_2023_05_007
crossref_primary_10_3390_jcm10112451
crossref_primary_10_3389_fcvm_2021_690533
crossref_primary_10_1016_j_numecd_2019_11_016
crossref_primary_10_1016_j_thromres_2022_01_003
crossref_primary_10_3390_pharmaceutics13060766
crossref_primary_10_1159_000514207
crossref_primary_10_1007_s11886_023_01906_6
crossref_primary_10_1093_ehjci_jead168
crossref_primary_10_3390_jcm13102887
crossref_primary_10_1186_s12885_020_07487_9
crossref_primary_10_1002_nbm_4845
crossref_primary_10_1016_j_nanoen_2024_109519
crossref_primary_10_3390_ijms252313185
crossref_primary_10_1177_00033197231152693
crossref_primary_10_1002_cncr_32085
crossref_primary_10_1016_j_bbrc_2018_12_160
crossref_primary_10_1016_j_ejim_2020_05_034
crossref_primary_10_2174_1573407219666230907115809
crossref_primary_10_1096_fj_202500198R
crossref_primary_10_21518_1561_5936_2019_12_36_43
crossref_primary_10_12997_jla_2025_14_1_30
crossref_primary_10_1158_0008_5472_CAN_18_1677
crossref_primary_10_1016_j_pcad_2019_02_002
crossref_primary_10_1186_s12967_023_04680_9
crossref_primary_10_3389_fonc_2021_731249
crossref_primary_10_1055_a_2052_5681
crossref_primary_10_2147_CLEP_S262939
crossref_primary_10_1016_j_jaccao_2023_01_004
crossref_primary_10_1016_j_jacc_2020_03_067
crossref_primary_10_3390_jcm12185804
crossref_primary_10_1053_j_jvca_2020_02_052
crossref_primary_10_1016_j_jjcc_2022_03_013
crossref_primary_10_1016_j_mrrev_2020_108348
crossref_primary_10_1080_14740338_2022_1986001
crossref_primary_10_1038_s41598_019_39004_9
crossref_primary_10_12997_jla_2025_14_1_22
crossref_primary_10_1016_j_cpcardiol_2021_100958
crossref_primary_10_1186_s41043_023_00356_8
crossref_primary_10_1093_database_baad029
crossref_primary_10_1016_j_ajpc_2024_100926
crossref_primary_10_3389_fcvm_2023_1274976
crossref_primary_10_1159_000515473
crossref_primary_10_18786_2072_0505_2023_51_034
crossref_primary_10_3390_molecules27030789
crossref_primary_10_1111_cas_14652
crossref_primary_10_18332_tid_166110
crossref_primary_10_1093_jncics_pkaa108
crossref_primary_10_1093_humrep_dead110
crossref_primary_10_3389_fonc_2022_870086
crossref_primary_10_3390_antiox11030448
crossref_primary_10_1093_biostatistics_kxab016
crossref_primary_10_1002_cam4_3797
crossref_primary_10_23736_S0375_9393_24_18396_4
crossref_primary_10_1007_s10115_023_01862_1
crossref_primary_10_3390_ijms21239042
crossref_primary_10_1007_s10552_022_01560_3
crossref_primary_10_1093_jncics_pkad005
crossref_primary_10_1080_14779072_2021_1902306
crossref_primary_10_1111_jdi_13265
crossref_primary_10_1161_JAHA_118_008769
crossref_primary_10_1172_jci_insight_123047
crossref_primary_10_1186_s12916_019_1474_7
crossref_primary_10_1186_s12872_019_1092_5
crossref_primary_10_1080_10428194_2024_2364830
crossref_primary_10_1007_s00392_020_01615_y
crossref_primary_10_3390_cells8050381
crossref_primary_10_18632_oncotarget_27814
crossref_primary_10_1155_2022_4570926
crossref_primary_10_1007_s00395_024_01046_0
crossref_primary_10_1007_s00395_024_01088_4
crossref_primary_10_1002_ehf2_14668
crossref_primary_10_1177_1538574418764055
crossref_primary_10_1016_j_jaccao_2020_12_003
crossref_primary_10_1158_1055_9965_EPI_21_0610
crossref_primary_10_3389_fnut_2022_847421
crossref_primary_10_1007_s11912_022_01212_4
crossref_primary_10_1038_s41569_022_00698_6
crossref_primary_10_1002_cbf_4018
crossref_primary_10_1007_s11912_023_01426_0
crossref_primary_10_33435_tcandtc_1102295
crossref_primary_10_1002_cam4_6603
crossref_primary_10_1007_s11010_020_04022_z
crossref_primary_10_3390_biology11020300
crossref_primary_10_1016_j_jtha_2024_12_008
crossref_primary_10_1186_s12967_023_04498_5
crossref_primary_10_3390_molecules25112653
crossref_primary_10_1161_CIRCULATIONAHA_118_035516
crossref_primary_10_1093_cvr_cvae055
crossref_primary_10_1016_j_resuscitation_2022_07_032
crossref_primary_10_3390_cancers15020512
crossref_primary_10_3389_fgene_2020_00320
crossref_primary_10_4048_jbc_2024_0085
crossref_primary_10_1186_s12967_024_06027_4
crossref_primary_10_1186_s12885_024_12053_8
crossref_primary_10_1016_j_ebiom_2020_103193
crossref_primary_10_1038_s41416_022_01935_y
crossref_primary_10_1016_j_ypmed_2021_106530
crossref_primary_10_1007_s11239_020_02273_7
crossref_primary_10_1111_eci_14255
crossref_primary_10_3389_fcvm_2020_00148
crossref_primary_10_1007_s11883_022_01021_x
crossref_primary_10_1155_2023_2404806
crossref_primary_10_1097_HCO_0000000000000767
crossref_primary_10_1016_j_ijcard_2019_01_082
crossref_primary_10_1002_hsr2_256
crossref_primary_10_1097_FJC_0000000000000660
crossref_primary_10_1016_j_bbrep_2025_101970
crossref_primary_10_1093_cvr_cvaa244
crossref_primary_10_3390_nu12041066
crossref_primary_10_1007_s11864_022_00978_w
crossref_primary_10_1186_s40959_023_00196_9
crossref_primary_10_4070_kcj_2020_0158
crossref_primary_10_3390_curroncol28050313
Cites_doi 10.1016/j.vph.2015.08.012
10.1196/annals.1414.011
10.1371/journal.pone.0036565
10.1073/pnas.0911220107
10.1016/j.arcmed.2011.11.009
10.1056/NEJMp1213380
10.4239/wjd.v6.i2.352
10.1056/NEJMoa1301824
10.1056/NEJMoa043792
10.14310/horm.2002.1671
10.1073/pnas.93.12.5793
10.1179/1743132815Y.0000000008
10.3390/ijms14035560
10.1016/j.atherosclerosis.2012.12.029
10.3748/wjg.v20.i23.7137
10.1016/S0140-6736(00)04046-0
10.1097/01.mnh.0000196146.65330.ea
10.1016/j.jacc.2006.12.048
10.1172/JCI24140
10.1038/nrc3215
10.1073/pnas.1019443108
10.1161/01.STR.0000257974.06317.49
10.1111/joim.12012
10.1186/1471-2407-6-268
10.1016/S0140-6736(04)17018-9
10.1016/j.jvs.2008.10.004
10.2337/dc07-2131
10.1016/j.bbrc.2004.06.133
10.3892/ijmm.2014.1942
10.1016/0896-6273(95)90286-4
10.1161/CIRCRESAHA.108.183863
10.18632/oncotarget.2769
10.1186/1471-2350-14-8
10.1136/bmj.38415.708634.F7
10.1016/j.celrep.2015.09.028
10.1158/0008-5472.CAN-04-3025
10.1016/j.cmet.2011.03.009
10.1016/j.bcp.2004.01.020
10.1038/onc.2009.339
10.1523/JNEUROSCI.4288-03.2004
10.4049/jimmunol.1000181
10.1111/j.1748-1716.2009.01980.x
10.1074/jbc.M111.295287
10.1016/j.bbrc.2015.05.108
10.1016/S0140-6736(09)61965-6
10.1016/j.metabol.2011.10.013
10.1016/S0140-6736(09)60503-1
10.1158/1541-7786.MCR-05-0261
10.1155/2012/968040
10.1074/jbc.M110.100321
10.1159/000069792
10.1002/humu.22360
10.1186/1471-2350-10-15
10.1126/science.1136370
10.1517/14728222.2014.938051
10.1016/j.devcel.2009.06.016
10.3181/00379727-210-43942
10.1007/s12013-011-9253-x
10.2174/138945011797635803
10.1016/S0140-6736(10)61543-7
10.1038/450494a
10.1074/jbc.M212831200
10.1038/emm.2016.16
10.1016/j.atherosclerosis.2007.05.026
10.1161/CIRCULATIONAHA.107.696922
10.1007/s00592-013-0504-8
10.1111/j.1365-2141.2012.09074.x
10.1161/ATVBAHA.111.241927
10.1007/s00277-014-2236-4
10.1016/j.ccr.2012.12.008
10.1053/j.gastro.2009.01.053
10.1016/S0140-6736(98)03228-0
10.1038/labinvest.2008.97
10.1002/jcp.20472
10.2174/156652410793384187
10.1016/j.cmet.2013.01.009
10.1016/j.annepidem.2011.10.006
10.1016/S0140-6736(11)61654-1
10.1161/01.ATV.21.3.372
10.4103/2230-8210.163106
10.1016/j.tem.2005.07.009
10.1016/j.ejphar.2015.10.057
10.1007/s12020-012-9821-x
10.1074/jbc.M111.286724
10.1016/j.pharmthera.2010.11.002
10.1016/S0140-6736(05)67528-9
10.1016/S0140-6736(08)60269-X
10.1684/ecn.2011.0295
10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1
10.1016/j.jacc.2014.03.049
10.1093/jnci/djs377
10.18632/genesandcancer.29
10.1016/j.ejmg.2014.10.004
10.1016/j.tem.2012.06.001
10.1016/j.yjmcc.2015.07.005
10.1517/14712598.6.3.243
10.1016/j.canlet.2013.08.014
10.1210/endo.142.7.8272
10.1097/HCO.0b013e3283470359
10.1016/S0140-6736(10)62110-1
10.1016/j.freeradbiomed.2012.02.035
10.1038/cgt.2014.16
10.1177/1474515111430928
10.1007/s00109-007-0203-4
10.1038/sj.onc.1208555
10.2353/ajpath.2009.080611
10.1002/ppul.20338
10.1016/j.gene.2015.03.062
10.1016/S0083-6729(08)00413-5
10.1016/j.bbrc.2006.06.082
10.1093/carcin/bgp127
10.1093/carcin/bgg032
10.1016/S0014-5793(02)03110-1
10.1016/j.atherosclerosis.2008.05.029
10.1016/j.bmcl.2015.08.087
10.1074/jbc.M104091200
10.1002/ijc.23173
10.1016/j.jamcollsurg.2007.01.067
10.1053/euhj.1999.1914
10.1016/j.jns.2012.07.038
10.1038/onc.2014.416
10.2174/1570161043385556
10.1016/j.cell.2013.06.030
10.1007/s10549-012-2299-7
10.1371/journal.pone.0017978
10.3109/00207454.2014.984295
10.1155/2008/431763
10.4161/cbt.8.17.9322
10.1016/j.cmet.2013.11.023
10.1016/j.jjcc.2015.05.004
10.1016/S0140-6736(11)61720-0
10.1152/ajpheart.00982.2007
10.1530/JME-13-0152
10.1113/jphysiol.2006.108324
10.1158/1940-6207.CAPR-10-0157
10.1038/ajg.2013.5
10.1038/sj.onc.1208123
10.1016/j.ehj.2003.12.007
10.1001/jama.298.10.1180
10.7150/ijms.10953
10.1210/me.2007-0421
10.1089/gtmb.2012.0295
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1016/j.atherosclerosis.2017.06.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1484
EndPage 351
ExternalDocumentID oai:pubmedcentral.nih.gov:6207942
PMC6207942
28624099
10_1016_j_atherosclerosis_2017_06_001
S0021915017302484
1_s2_0_S0021915017302484
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R35 HL135767
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
0SF
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c616t-cad185f8cdf5ff2caefcc98d72871c46c5548c46a8dd769a6522d5293584dfd33
IEDL.DBID UNPAY
ISSN 0021-9150
1879-1484
IngestDate Wed Aug 20 00:05:06 EDT 2025
Tue Sep 30 16:45:18 EDT 2025
Sat Sep 27 21:51:33 EDT 2025
Mon Jul 21 06:06:10 EDT 2025
Wed Oct 01 05:14:22 EDT 2025
Thu Apr 24 23:06:57 EDT 2025
Fri Feb 23 02:49:21 EST 2024
Tue Feb 25 19:57:36 EST 2025
Tue Aug 26 16:36:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords CVD
T2DM
TZDs
CAD
RAAS
AMPK
PAI-1
VSMC
ACEIs/ARBs
PPAR-γ
WHO
Signaling pathways
Malignancy
Atherosclerosis
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c616t-cad185f8cdf5ff2caefcc98d72871c46c5548c46a8dd769a6522d5293584dfd33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
FMK was responsible for writing the draft of the manuscript, creating the figure and tables and performing major revision of the manuscript. NS developed the idea, wrote some parts, edited the whole manuscript and supervised the whole project. CG edited the whole manuscript and wrote some parts. AI contributed in idea development and edited the manuscript. AK was responsible for editing the whole manuscript and writing some parts. MD wrote the cardio-oncology section. CF critically edited the whole manuscript and shortened the manuscript. AM was responsible for scientific support of the genetic and molecular pathways and did the major revisions.
Author contributions
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.ncbi.nlm.nih.gov/pmc/articles/6207942
PMID 28624099
PQID 1911198889
PQPubID 23479
PageCount 9
ParticipantIDs unpaywall_primary_10_1016_j_atherosclerosis_2017_06_001
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6207942
proquest_miscellaneous_1911198889
pubmed_primary_28624099
crossref_citationtrail_10_1016_j_atherosclerosis_2017_06_001
crossref_primary_10_1016_j_atherosclerosis_2017_06_001
elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2017_06_001
elsevier_clinicalkeyesjournals_1_s2_0_S0021915017302484
elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2017_06_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-08-01
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2017
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References (bib5) 2002
Lee, Nathan Grantham, Trachte (bib7) 2006; 347
Paredes, Matta-Coelho, Monteiro (bib59) 2016; 15
Kang, Zhao, Liu (bib132) 2013; 17
Deshayes, Nahmias (bib8) 2005; 16
Lincoff, Wolski, Nicholls (bib57) 2007; 298
Wu, Liu, Pang (bib61) 2014; 34
Christman, Goetz, Dickerson (bib88) 2008; 294
Chogtu, Magazine, Bairy (bib142) 2015; 6
Rothwell, Price, Fowkes (bib10) 2012; 379
Chen, Ishibashi, Perrey (bib40) 2001; 21
Zhu, Hou, Pan (bib130) 2015; 125
El-Serag, Johnson, Hachem (bib139) 2009; 136
Liu, Prior, Piwnica-Worms (bib104) 2010; 107
Tong, Lin, Zhang (bib109) 2009; 10
Lu, Ouyang, Huang (bib21) 2006; 4
Decensi, Puntoni, Goodwin (bib37) 2010; 3
Vink, Schoneveld, Lamers (bib14) 2007; 195
Yan, Yang, Chen (bib47) 2014; 21
Ploplis (bib67) 2011; 12
Bian, Yu, Wang (bib66) 2015; 463
Shao, Cheng, Pingsterhaus (bib90) 2005; 115
Wang, Song, Srivastava (bib101) 2015; 29
Song, Wang, Mani (bib100) 2014; 5
Lemieux, Cagnol, Beaudry (bib106) 2015; 34
Sikka, Chen, Sethi (bib46) 2012; 2012
Monami, Dicembrini, Mannucci (bib53) 2014; 51
Lipscomb, Gotay, Snyder (bib2) 2007; 57
Olijhoek, van der Graaf, Banga (bib12) 2004; 25
Fang, Placencio, DeClerck (bib70) 2012; 104
Dormandy, Charbonnel, Eckland (bib55) 2005; 366
Connor, Baumgartner, Baumgartner (bib114) 2012; 136
Rothwell, Wilson, Elwin (bib158) 2010; 376
Tejedor, Zhu, Kaltenbach (bib117) 1995; 14
Keramati, Singh, Lin (bib86) 2011; 108
Reddy, Baskaran, Molteni (bib147) 1995; 210
Singh, De Aguiar, Naik (bib97) 2013; 17
Kavalipati, Shah, Ramakrishan (bib135) 2015; 19
Shackelford, Abt, Gerken (bib39) 2013; 23
Yoshiji, Kuriyama, Fukui (bib153) 2002; 23
Folsom, Pankow, Peacock (bib112) 2008; 31
Fleming, Kohlstedt, Busse (bib150) 2006; 15
Ando, Catalano (bib78) 2011; 8
Mani, Radhakrishnan, Wang (bib87) 2007; 315
Mughal, Kumar, Vikram (bib51) 2015; 768
Cauchi, El Achhab, Choquet (bib110) 2007; 85
Yusuf, Hawken, Ounpuu (bib71) 2004; 364
Evans, Donnelly, Emslie-Smith (bib36) 2005; 330
Thambyrajah, Townend (bib126) 2000; 21
Geng, Jin, Wu (bib54) 2009; 202
Wang, Yin, Liu (bib42) 2011; 75
Balkwill, Mantovani (bib16) 2001; 357
Chen, Li, Zhu (bib25) 2015; 85
Friedman (bib120) 2013; 14
Swinnen, Beckers, Brusselmans (bib29) 2005; 65
Xuan, Bai, Gao (bib125) 2011; 42
Li, Xu, Mihaylova (bib27) 2011; 13
Burwinkel, Shanmugam, Hemminki (bib116) 2006; 6
Kim, Kim, Kim (bib89) 2010; 185
Giri, Nath, Smith (bib28) 2004; 24
Meisse, Van de Casteele, Beauloye (bib31) 2002; 526
Pollak (bib50) 2012; 12
Alfieri, Mayosi, Park (bib160) 2014; 11
Thomas, Fenech (bib133) 2008; 79
Morrow, Foufelle, Connell (bib22) 2003; 278
Fiorentino, Zadra, Palescandolo (bib63) 2008; 88
Sattar, Preiss, Murray (bib143) 2010; 375
Garcia-Jimenez, Garcia-Martinez, Chocarro-Calvo (bib84) 2014; 52
Zhang, Li, Liu (bib105) 2010; 29
Liew, Gupta (bib127) 2015; 58
Singh, Singh, Singh (bib38) 2013; 108
Muendlein, Saely, Geller-Rhomberg (bib107) 2011; 6
Mc Menamin, Murray, Cantwell (bib9) 2012; 23
Ye, Go, Singh (bib96) 2012; 287
Sampson, Linton, Fazio (bib144) 2011; 26
Montecucco, Mach (bib134) 2009; 23
Gao, Li, Xiao (bib131) 2012; 323
Sjostrom (bib73) 2013; 273
Ino, Shibata, Kajiyama (bib151) 2006; 6
Li, Jiang, Robinson (bib30) 2003; 24
Tajik, Keshavarz, Masoudkabir (bib77) 2013; 36
Prontera, Mariani, Rossi (bib148) 1999; 81
Parekh, Galloway, Hong (bib154) 2013; 368
Erdmann, Dormandy, Charbonnel (bib56) 2007; 49
Garofalo, Surmacz (bib79) 2006; 207
Karbaschian, Hosseinzadeh-Attar, Giahi (bib75) 2013; 44
Lever, Hole, Gillis (bib145) 1998; 352
Cabarcas, Hurt, Farrar (bib23) 2010; 10
Agrawal, Febbraio, Podrez (bib15) 2007; 115
Go, Mani (bib94) 2012; 85
Giaginis, Tsantili-Kakoulidou, Theocharis (bib82) 2008; 2008
Dickens, Cherrington, McGowan (bib3) 2012; 11
Escobar, Rodriguez-Reyna, Arrieta (bib149) 2004; 2
Pateras, Giaginis, Tsigris (bib13) 2014; 18
Denning, Stoll (bib52) 2006; 41
Li (bib123) 2012; 61
(bib6) 2011
Marinou, Christodoulides, Antoniades (bib91) 2012; 23
Liu, Mani, Davis (bib93) 2008; 103
Kumar, Kumar, Prasad (bib129) 2015; 37
Pizer, Jackisch, Wood (bib65) 1996; 56
Tajik, Golpaie, Keshavarz (bib76) 2012; 35
Daar, Singer, Persad (bib4) 2007; 450
Khandanpour, Willis, Meyer (bib128) 2009; 49
Saitoh, Nagai, Nakagawa (bib32) 2004; 67
Sabatino, Pancione, Votino (bib45) 2014; 20
Hirabayashi, Baranski, Cagan (bib92) 2013; 154
Ivanova, Parolari, Myasoedova (bib43) 2015; 66
Motoshima, Goldstein, Igata (bib26) 2006; 574
Liu, Singh, Choi (bib95) 2012; 287
Domenyuk, Litovkin, Verbitskaya (bib113) 2007; 29
Hussain, Harris (bib18) 2007; 121
Mullen, Yet (bib62) 2015; 25
Hursting, Hursting (bib69) 2012; 32
Conzen (bib48) 2008; 22
Liu, Dai, Xu (bib49) 2012; 62
Tung, Wong, Yau (bib103) 2012; 7
(bib1) 2014
Wilcox, Bousser, Betteridge (bib58) 2007; 38
Sugawara, Takeuchi, Uruno (bib44) 2001; 142
Renehan, Tyson, Egger (bib72) 2008; 371
Rothwell, Fowkes, Belch (bib159) 2011; 377
Wu, Antony, Meitzler (bib20) 2014; 345
Chen, Huang, Huang (bib115) 2015; 12
Wang, Hu, Feng (bib108) 2013; 14
Keramati, Fathzadeh, Go (bib122) 2014; 370
Taylor, Cook, Sheffield (bib152) 1988; 130
Go, Srivastava, Hernandez-Ono (bib99) 2014; 19
Arafat, Gong, Chipitsyna (bib146) 2007; 204
Colotta, Allavena, Sica (bib19) 2009; 30
Corcos, Le Jossic-Corcos (bib140) 2013; 45
Chan, Cook (bib157) 2012; 379
Kallen, Lazar (bib81) 1996; 93
Yang, Ahn, Chung (bib118) 2001; 276
Simon, Rosenberg, Rodabough (bib137) 2012; 22
Shah, Mahmoudi (bib141) 2015; 86
Kundu, Surh (bib17) 2012; 52
Ntaios, Gatselis, Makaritsis (bib80) 2013; 227
Singh, Smith, Fathzadeh (bib98) 2013; 34
Nakaya, Summers, Nicholson (bib41) 2009; 174
Li, Lu, He (bib102) 2004; 23
Wang, Jiang, Li (bib111) 2015; 8
Baigent, Blackwell, Collins (bib156) 2009; 373
Bockorny, Dasanu (bib136) 2015; 94
Kim, Yang, Kim (bib35) 2016; 48
Halvorsen, Andreotti, ten Berg (bib155) 2014; 64
Ewart, Kennedy (bib24) 2011; 131
Bandyopadhyay, Pai, Watabe (bib64) 2005; 24
Xiang, Saha, Wen (bib33) 2004; 321
Hou, Chen, Shi (bib124) 2015; 565
Wang, Guan (bib34) 2009; 196
Srivastava, Zhang, Go (bib85) 2015; 13
Gao, Zheng, Rawal (bib121) 2009; 8
Schneider, Yang, Chakravarthy (bib60) 2010; 285
Golpaie, Tajik, Masoudkabir (bib74) 2011; 22
Deng, Friedman (bib119) 2014; 5
MacDonald, Tamai, He (bib83) 2009; 17
Poynter, Gruber, Higgins (bib138) 2005; 352
Attoub, Gaben, Al-Salam (bib11) 2008; 1138
Iwaki, Urano, Umemura (bib68) 2012; 157
Christman (10.1016/j.atherosclerosis.2017.06.001_bib88) 2008; 294
Tong (10.1016/j.atherosclerosis.2017.06.001_bib109) 2009; 10
Alfieri (10.1016/j.atherosclerosis.2017.06.001_bib160) 2014; 11
Tajik (10.1016/j.atherosclerosis.2017.06.001_bib77) 2013; 36
Yang (10.1016/j.atherosclerosis.2017.06.001_bib118) 2001; 276
Wilcox (10.1016/j.atherosclerosis.2017.06.001_bib58) 2007; 38
Li (10.1016/j.atherosclerosis.2017.06.001_bib27) 2011; 13
Lu (10.1016/j.atherosclerosis.2017.06.001_bib21) 2006; 4
Vink (10.1016/j.atherosclerosis.2017.06.001_bib14) 2007; 195
Marinou (10.1016/j.atherosclerosis.2017.06.001_bib91) 2012; 23
El-Serag (10.1016/j.atherosclerosis.2017.06.001_bib139) 2009; 136
Chen (10.1016/j.atherosclerosis.2017.06.001_bib25) 2015; 85
Garcia-Jimenez (10.1016/j.atherosclerosis.2017.06.001_bib84) 2014; 52
Lipscomb (10.1016/j.atherosclerosis.2017.06.001_bib2) 2007; 57
Balkwill (10.1016/j.atherosclerosis.2017.06.001_bib16) 2001; 357
Zhang (10.1016/j.atherosclerosis.2017.06.001_bib105) 2010; 29
Sabatino (10.1016/j.atherosclerosis.2017.06.001_bib45) 2014; 20
Hirabayashi (10.1016/j.atherosclerosis.2017.06.001_bib92) 2013; 154
Sugawara (10.1016/j.atherosclerosis.2017.06.001_bib44) 2001; 142
Attoub (10.1016/j.atherosclerosis.2017.06.001_bib11) 2008; 1138
Garofalo (10.1016/j.atherosclerosis.2017.06.001_bib79) 2006; 207
Mullen (10.1016/j.atherosclerosis.2017.06.001_bib62) 2015; 25
Mc Menamin (10.1016/j.atherosclerosis.2017.06.001_bib9) 2012; 23
Gao (10.1016/j.atherosclerosis.2017.06.001_bib121) 2009; 8
Hursting (10.1016/j.atherosclerosis.2017.06.001_bib69) 2012; 32
Denning (10.1016/j.atherosclerosis.2017.06.001_bib52) 2006; 41
Lincoff (10.1016/j.atherosclerosis.2017.06.001_bib57) 2007; 298
Tejedor (10.1016/j.atherosclerosis.2017.06.001_bib117) 1995; 14
Sjostrom (10.1016/j.atherosclerosis.2017.06.001_bib73) 2013; 273
Kumar (10.1016/j.atherosclerosis.2017.06.001_bib129) 2015; 37
Sampson (10.1016/j.atherosclerosis.2017.06.001_bib144) 2011; 26
Escobar (10.1016/j.atherosclerosis.2017.06.001_bib149) 2004; 2
Tung (10.1016/j.atherosclerosis.2017.06.001_bib103) 2012; 7
(10.1016/j.atherosclerosis.2017.06.001_bib5) 2002
Ntaios (10.1016/j.atherosclerosis.2017.06.001_bib80) 2013; 227
Lemieux (10.1016/j.atherosclerosis.2017.06.001_bib106) 2015; 34
Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib158) 2010; 376
Reddy (10.1016/j.atherosclerosis.2017.06.001_bib147) 1995; 210
Yoshiji (10.1016/j.atherosclerosis.2017.06.001_bib153) 2002; 23
Kallen (10.1016/j.atherosclerosis.2017.06.001_bib81) 1996; 93
Chen (10.1016/j.atherosclerosis.2017.06.001_bib115) 2015; 12
Shah (10.1016/j.atherosclerosis.2017.06.001_bib141) 2015; 86
Yusuf (10.1016/j.atherosclerosis.2017.06.001_bib71) 2004; 364
Li (10.1016/j.atherosclerosis.2017.06.001_bib123) 2012; 61
Paredes (10.1016/j.atherosclerosis.2017.06.001_bib59) 2016; 15
Corcos (10.1016/j.atherosclerosis.2017.06.001_bib140) 2013; 45
Go (10.1016/j.atherosclerosis.2017.06.001_bib94) 2012; 85
Xuan (10.1016/j.atherosclerosis.2017.06.001_bib125) 2011; 42
Li (10.1016/j.atherosclerosis.2017.06.001_bib30) 2003; 24
Sikka (10.1016/j.atherosclerosis.2017.06.001_bib46) 2012; 2012
Geng (10.1016/j.atherosclerosis.2017.06.001_bib54) 2009; 202
Fleming (10.1016/j.atherosclerosis.2017.06.001_bib150) 2006; 15
Ivanova (10.1016/j.atherosclerosis.2017.06.001_bib43) 2015; 66
Liew (10.1016/j.atherosclerosis.2017.06.001_bib127) 2015; 58
Dickens (10.1016/j.atherosclerosis.2017.06.001_bib3) 2012; 11
Ewart (10.1016/j.atherosclerosis.2017.06.001_bib24) 2011; 131
Iwaki (10.1016/j.atherosclerosis.2017.06.001_bib68) 2012; 157
Wu (10.1016/j.atherosclerosis.2017.06.001_bib20) 2014; 345
Pateras (10.1016/j.atherosclerosis.2017.06.001_bib13) 2014; 18
Cabarcas (10.1016/j.atherosclerosis.2017.06.001_bib23) 2010; 10
Parekh (10.1016/j.atherosclerosis.2017.06.001_bib154) 2013; 368
Kavalipati (10.1016/j.atherosclerosis.2017.06.001_bib135) 2015; 19
Colotta (10.1016/j.atherosclerosis.2017.06.001_bib19) 2009; 30
Xiang (10.1016/j.atherosclerosis.2017.06.001_bib33) 2004; 321
Karbaschian (10.1016/j.atherosclerosis.2017.06.001_bib75) 2013; 44
Yan (10.1016/j.atherosclerosis.2017.06.001_bib47) 2014; 21
Monami (10.1016/j.atherosclerosis.2017.06.001_bib53) 2014; 51
Bandyopadhyay (10.1016/j.atherosclerosis.2017.06.001_bib64) 2005; 24
Motoshima (10.1016/j.atherosclerosis.2017.06.001_bib26) 2006; 574
Golpaie (10.1016/j.atherosclerosis.2017.06.001_bib74) 2011; 22
Agrawal (10.1016/j.atherosclerosis.2017.06.001_bib15) 2007; 115
Morrow (10.1016/j.atherosclerosis.2017.06.001_bib22) 2003; 278
Kim (10.1016/j.atherosclerosis.2017.06.001_bib35) 2016; 48
Wang (10.1016/j.atherosclerosis.2017.06.001_bib101) 2015; 29
Burwinkel (10.1016/j.atherosclerosis.2017.06.001_bib116) 2006; 6
Mani (10.1016/j.atherosclerosis.2017.06.001_bib87) 2007; 315
Kang (10.1016/j.atherosclerosis.2017.06.001_bib132) 2013; 17
Wu (10.1016/j.atherosclerosis.2017.06.001_bib61) 2014; 34
Lee (10.1016/j.atherosclerosis.2017.06.001_bib7) 2006; 347
(10.1016/j.atherosclerosis.2017.06.001_bib6) 2011
Singh (10.1016/j.atherosclerosis.2017.06.001_bib38) 2013; 108
Liu (10.1016/j.atherosclerosis.2017.06.001_bib104) 2010; 107
Conzen (10.1016/j.atherosclerosis.2017.06.001_bib48) 2008; 22
Saitoh (10.1016/j.atherosclerosis.2017.06.001_bib32) 2004; 67
Bockorny (10.1016/j.atherosclerosis.2017.06.001_bib136) 2015; 94
Ino (10.1016/j.atherosclerosis.2017.06.001_bib151) 2006; 6
Keramati (10.1016/j.atherosclerosis.2017.06.001_bib86) 2011; 108
Prontera (10.1016/j.atherosclerosis.2017.06.001_bib148) 1999; 81
Friedman (10.1016/j.atherosclerosis.2017.06.001_bib120) 2013; 14
Simon (10.1016/j.atherosclerosis.2017.06.001_bib137) 2012; 22
Fiorentino (10.1016/j.atherosclerosis.2017.06.001_bib63) 2008; 88
Ando (10.1016/j.atherosclerosis.2017.06.001_bib78) 2011; 8
Domenyuk (10.1016/j.atherosclerosis.2017.06.001_bib113) 2007; 29
Pollak (10.1016/j.atherosclerosis.2017.06.001_bib50) 2012; 12
Liu (10.1016/j.atherosclerosis.2017.06.001_bib93) 2008; 103
Poynter (10.1016/j.atherosclerosis.2017.06.001_bib138) 2005; 352
Sattar (10.1016/j.atherosclerosis.2017.06.001_bib143) 2010; 375
Giaginis (10.1016/j.atherosclerosis.2017.06.001_bib82) 2008; 2008
Deshayes (10.1016/j.atherosclerosis.2017.06.001_bib8) 2005; 16
MacDonald (10.1016/j.atherosclerosis.2017.06.001_bib83) 2009; 17
Connor (10.1016/j.atherosclerosis.2017.06.001_bib114) 2012; 136
Dormandy (10.1016/j.atherosclerosis.2017.06.001_bib55) 2005; 366
Wang (10.1016/j.atherosclerosis.2017.06.001_bib111) 2015; 8
Kundu (10.1016/j.atherosclerosis.2017.06.001_bib17) 2012; 52
Lever (10.1016/j.atherosclerosis.2017.06.001_bib145) 1998; 352
Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib10) 2012; 379
Liu (10.1016/j.atherosclerosis.2017.06.001_bib95) 2012; 287
Gao (10.1016/j.atherosclerosis.2017.06.001_bib131) 2012; 323
Arafat (10.1016/j.atherosclerosis.2017.06.001_bib146) 2007; 204
Taylor (10.1016/j.atherosclerosis.2017.06.001_bib152) 1988; 130
Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib159) 2011; 377
Decensi (10.1016/j.atherosclerosis.2017.06.001_bib37) 2010; 3
Shackelford (10.1016/j.atherosclerosis.2017.06.001_bib39) 2013; 23
Cauchi (10.1016/j.atherosclerosis.2017.06.001_bib110) 2007; 85
Swinnen (10.1016/j.atherosclerosis.2017.06.001_bib29) 2005; 65
Srivastava (10.1016/j.atherosclerosis.2017.06.001_bib85) 2015; 13
Chen (10.1016/j.atherosclerosis.2017.06.001_bib40) 2001; 21
Li (10.1016/j.atherosclerosis.2017.06.001_bib102) 2004; 23
Baigent (10.1016/j.atherosclerosis.2017.06.001_bib156) 2009; 373
(10.1016/j.atherosclerosis.2017.06.001_bib1) 2014
Schneider (10.1016/j.atherosclerosis.2017.06.001_bib60) 2010; 285
Erdmann (10.1016/j.atherosclerosis.2017.06.001_bib56) 2007; 49
Shao (10.1016/j.atherosclerosis.2017.06.001_bib90) 2005; 115
Daar (10.1016/j.atherosclerosis.2017.06.001_bib4) 2007; 450
Folsom (10.1016/j.atherosclerosis.2017.06.001_bib112) 2008; 31
Hussain (10.1016/j.atherosclerosis.2017.06.001_bib18) 2007; 121
Zhu (10.1016/j.atherosclerosis.2017.06.001_bib130) 2015; 125
Nakaya (10.1016/j.atherosclerosis.2017.06.001_bib41) 2009; 174
Meisse (10.1016/j.atherosclerosis.2017.06.001_bib31) 2002; 526
Tajik (10.1016/j.atherosclerosis.2017.06.001_bib76) 2012; 35
Chogtu (10.1016/j.atherosclerosis.2017.06.001_bib142) 2015; 6
Keramati (10.1016/j.atherosclerosis.2017.06.001_bib122) 2014; 370
Halvorsen (10.1016/j.atherosclerosis.2017.06.001_bib155) 2014; 64
Muendlein (10.1016/j.atherosclerosis.2017.06.001_bib107) 2011; 6
Khandanpour (10.1016/j.atherosclerosis.2017.06.001_bib128) 2009; 49
Mughal (10.1016/j.atherosclerosis.2017.06.001_bib51) 2015; 768
Singh (10.1016/j.atherosclerosis.2017.06.001_bib98) 2013; 34
Wang (10.1016/j.atherosclerosis.2017.06.001_bib108) 2013; 14
Liu (10.1016/j.atherosclerosis.2017.06.001_bib49) 2012; 62
Hou (10.1016/j.atherosclerosis.2017.06.001_bib124) 2015; 565
Go (10.1016/j.atherosclerosis.2017.06.001_bib99) 2014; 19
Chan (10.1016/j.atherosclerosis.2017.06.001_bib157) 2012; 379
Wang (10.1016/j.atherosclerosis.2017.06.001_bib42) 2011; 75
Wang (10.1016/j.atherosclerosis.2017.06.001_bib34) 2009; 196
Deng (10.1016/j.atherosclerosis.2017.06.001_bib119) 2014; 5
Bian (10.1016/j.atherosclerosis.2017.06.001_bib66) 2015; 463
Ploplis (10.1016/j.atherosclerosis.2017.06.001_bib67) 2011; 12
Thomas (10.1016/j.atherosclerosis.2017.06.001_bib133) 2008; 79
Montecucco (10.1016/j.atherosclerosis.2017.06.001_bib134) 2009; 23
Song (10.1016/j.atherosclerosis.2017.06.001_bib100) 2014; 5
Kim (10.1016/j.atherosclerosis.2017.06.001_bib89) 2010; 185
Ye (10.1016/j.atherosclerosis.2017.06.001_bib96) 2012; 287
Renehan (10.1016/j.atherosclerosis.2017.06.001_bib72) 2008; 371
Olijhoek (10.1016/j.atherosclerosis.2017.06.001_bib12) 2004; 25
Fang (10.1016/j.atherosclerosis.2017.06.001_bib70) 2012; 104
Evans (10.1016/j.atherosclerosis.2017.06.001_bib36) 2005; 330
Giri (10.1016/j.atherosclerosis.2017.06.001_bib28) 2004; 24
Thambyrajah (10.1016/j.atherosclerosis.2017.06.001_bib126) 2000; 21
Singh (10.1016/j.atherosclerosis.2017.06.001_bib97) 2013; 17
Pizer (10.1016/j.atherosclerosis.2017.06.001_bib65) 1996; 56
References_xml – volume: 368
  start-page: 204
  year: 2013
  end-page: 205
  ident: bib154
  article-title: Aspirin in the secondary prevention of cardiovascular disease
  publication-title: N. Engl. J. Med.
– year: 2002
  ident: bib5
  publication-title: The World Health Report 2002-Reducing Risks, Promoting Healthy Life
– volume: 12
  start-page: 159
  year: 2012
  end-page: 169
  ident: bib50
  article-title: The insulin and insulin-like growth factor receptor family in neoplasia: an update
  publication-title: Nat. Rev. Cancer
– volume: 373
  start-page: 1849
  year: 2009
  end-page: 1860
  ident: bib156
  article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
  publication-title: Lancet (Lond. Engl.)
– volume: 13
  start-page: 376
  year: 2011
  end-page: 388
  ident: bib27
  article-title: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice
  publication-title: Cell Metab.
– volume: 364
  start-page: 937
  year: 2004
  end-page: 952
  ident: bib71
  article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  publication-title: Lancet (Lond. Engl.)
– volume: 273
  start-page: 219
  year: 2013
  end-page: 234
  ident: bib73
  article-title: Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
  publication-title: J. Intern. Med.
– volume: 5
  start-page: 11000
  year: 2014
  end-page: 11003
  ident: bib100
  article-title: Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
  publication-title: Oncotarget
– volume: 195
  start-page: e69
  year: 2007
  end-page: 75
  ident: bib14
  article-title: HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages
  publication-title: Atherosclerosis
– volume: 298
  start-page: 1180
  year: 2007
  end-page: 1188
  ident: bib57
  article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials
  publication-title: Jama
– volume: 352
  start-page: 179
  year: 1998
  end-page: 184
  ident: bib145
  article-title: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
  publication-title: Lancet (Lond. Engl.)
– volume: 15
  start-page: 170
  year: 2016
  end-page: 185
  ident: bib59
  article-title: Cardiovascular safety of type 2 diabetes medications: review of existing literature and clinical implications
  publication-title: Horm. (Athens, Greece)
– volume: 121
  start-page: 2373
  year: 2007
  end-page: 2380
  ident: bib18
  article-title: Inflammation and cancer: an ancient link with novel potentials
  publication-title: Int. J. Cancer. J. Int. du Cancer
– volume: 278
  start-page: 31629
  year: 2003
  end-page: 31639
  ident: bib22
  article-title: Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells
  publication-title: J. Biol. Chem.
– volume: 51
  start-page: 91
  year: 2014
  end-page: 101
  ident: bib53
  article-title: Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
  publication-title: Acta Diabetol.
– volume: 11
  start-page: 265
  year: 2012
  end-page: 275
  ident: bib3
  article-title: Depression and health-related quality of life in people with coronary heart disease: a systematic review
  publication-title: Eur. J. Cardiovasc. Nurs.
– volume: 2012
  start-page: 968040
  year: 2012
  ident: bib46
  article-title: Targeting PPARgamma signaling cascade for the prevention and treatment of prostate cancer
  publication-title: PPAR Res.
– volume: 108
  start-page: 881
  year: 2013
  end-page: 891
  ident: bib38
  article-title: Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis
  publication-title: Am. J. Gastroenterol.
– volume: 34
  start-page: 4914
  year: 2015
  end-page: 4927
  ident: bib106
  article-title: Oncogenic KRAS signalling promotes the Wnt/beta-catenin pathway through LRP6 in colorectal cancer
  publication-title: Oncogene
– year: 2011
  ident: bib6
  publication-title: Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases
– volume: 24
  start-page: 827
  year: 2003
  end-page: 834
  ident: bib30
  article-title: AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression
  publication-title: Carcinogenesis
– volume: 29
  start-page: 539
  year: 2010
  end-page: 549
  ident: bib105
  article-title: Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis
  publication-title: Oncogene
– volume: 81
  start-page: 761
  year: 1999
  end-page: 766
  ident: bib148
  article-title: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
  publication-title: Int. J. Cancer J. Int. du Cancer
– volume: 35
  start-page: 566
  year: 2012
  end-page: 569
  ident: bib76
  article-title: Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women
  publication-title: J. Endocrinol. Investig.
– volume: 565
  start-page: 39
  year: 2015
  end-page: 44
  ident: bib124
  article-title: Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis
  publication-title: Gene
– volume: 768
  start-page: 217
  year: 2015
  end-page: 225
  ident: bib51
  article-title: Effects of Thiazolidinediones on metabolism and cancer: relative influence of PPARgamma and IGF-1 signaling
  publication-title: Eur. J. Pharmacol.
– volume: 23
  start-page: 221
  year: 2012
  end-page: 230
  ident: bib9
  article-title: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
  publication-title: Cancer Causes Control CCC
– volume: 19
  start-page: 554
  year: 2015
  end-page: 562
  ident: bib135
  article-title: Pleiotropic effects of statins
  publication-title: Indian J. Endocrinol. Metab.
– volume: 48
  start-page: e224
  year: 2016
  ident: bib35
  article-title: AMPK activators: mechanisms of action and physiological activities
  publication-title: Exp. Mol. Med.
– volume: 2008
  start-page: 431763
  year: 2008
  ident: bib82
  article-title: Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancer
  publication-title: PPAR Res.
– volume: 23
  start-page: 628
  year: 2012
  end-page: 636
  ident: bib91
  article-title: Wnt signaling in cardiovascular physiology
  publication-title: Trends Endocrinol. Metab. TEM
– volume: 44
  start-page: 114
  year: 2013
  end-page: 118
  ident: bib75
  article-title: Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery
  publication-title: Endocrine
– volume: 2
  start-page: 385
  year: 2004
  end-page: 399
  ident: bib149
  article-title: Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer
  publication-title: Curr. Vasc. Pharmacol.
– volume: 174
  start-page: 2007
  year: 2009
  end-page: 2014
  ident: bib41
  article-title: Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone
  publication-title: Am. J. Pathol.
– volume: 202
  start-page: 521
  year: 2009
  end-page: 528
  ident: bib54
  article-title: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials
  publication-title: Atherosclerosis
– volume: 49
  start-page: 1772
  year: 2007
  end-page: 1780
  ident: bib56
  article-title: The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study
  publication-title: J. Am. Coll. Cardiol.
– volume: 21
  start-page: 372
  year: 2001
  end-page: 377
  ident: bib40
  article-title: Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 21
  start-page: 967
  year: 2000
  end-page: 974
  ident: bib126
  article-title: Homocysteine and atherothrombosis–mechanisms for injury
  publication-title: Eur. Heart J.
– volume: 61
  start-page: 846
  year: 2012
  end-page: 852
  ident: bib123
  article-title: Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis
  publication-title: Metab. Clin. Exp.
– volume: 34
  start-page: 1706
  year: 2014
  end-page: 1712
  ident: bib61
  article-title: Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-alpha
  publication-title: Int. J. Mol. Med.
– volume: 29
  start-page: 3436
  year: 2015
  end-page: 3445
  ident: bib101
  article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a
  publication-title: FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol.
– volume: 136
  start-page: 593
  year: 2012
  end-page: 602
  ident: bib114
  article-title: Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study
  publication-title: Breast Cancer Res. Treat.
– volume: 19
  start-page: 209
  year: 2014
  end-page: 220
  ident: bib99
  article-title: The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue
  publication-title: Cell Metab.
– volume: 10
  start-page: 15
  year: 2009
  ident: bib109
  article-title: Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis
  publication-title: BMC Med. Genet.
– volume: 157
  start-page: 291
  year: 2012
  end-page: 298
  ident: bib68
  article-title: PAI-1, progress in understanding the clinical problem and its aetiology
  publication-title: Br. J. Haematol.
– volume: 357
  start-page: 539
  year: 2001
  end-page: 545
  ident: bib16
  article-title: Inflammation and cancer: back to Virchow?
  publication-title: Lancet (Lond. Engl.)
– volume: 20
  start-page: 7137
  year: 2014
  end-page: 7151
  ident: bib45
  article-title: Emerging role of the beta-catenin-PPARgamma axis in the pathogenesis of colorectal cancer
  publication-title: World J. Gastroenterol.
– volume: 17
  start-page: 9
  year: 2009
  end-page: 26
  ident: bib83
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev. Cell
– volume: 12
  start-page: 1782
  year: 2011
  end-page: 1789
  ident: bib67
  article-title: Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease
  publication-title: Curr. Drug Targets
– volume: 14
  start-page: 5560
  year: 2013
  end-page: 5575
  ident: bib120
  article-title: Mirk/dyrk1B kinase in ovarian cancer
  publication-title: Int. J. Mol. Sci.
– volume: 154
  start-page: 664
  year: 2013
  end-page: 675
  ident: bib92
  article-title: Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling
  publication-title: Cell
– volume: 196
  start-page: 55
  year: 2009
  end-page: 63
  ident: bib34
  article-title: AMP-activated protein kinase and cancer
  publication-title: Acta Physiol. (Oxf. Engl.)
– volume: 12
  start-page: 243
  year: 2015
  end-page: 247
  ident: bib115
  article-title: Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer
  publication-title: Int. J. Med. Sci.
– volume: 37
  start-page: 568
  year: 2015
  end-page: 577
  ident: bib129
  article-title: Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis
  publication-title: Neurol. Res.
– volume: 370
  start-page: 1909
  year: 2014
  end-page: 1919
  ident: bib122
  article-title: A form of the metabolic syndrome associated with mutations in DYRK1B
  publication-title: N. Engl. J. Med.
– volume: 22
  start-page: 2215
  year: 2008
  end-page: 2228
  ident: bib48
  article-title: Minireview: nuclear receptors and breast cancer
  publication-title: Mol. Endocrinol. (Baltim. Md.)
– volume: 25
  start-page: 4363
  year: 2015
  end-page: 4369
  ident: bib62
  article-title: Progress in the development of fatty acid synthase inhibitors as anticancer targets
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 347
  start-page: 109
  year: 2006
  end-page: 116
  ident: bib7
  article-title: Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 276
  start-page: 39819
  year: 2001
  end-page: 39824
  ident: bib118
  article-title: Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells
  publication-title: J. Biol. Chem.
– volume: 131
  start-page: 242
  year: 2011
  end-page: 253
  ident: bib24
  article-title: AMPK and vasculoprotection
  publication-title: Pharmacol. Ther.
– volume: 26
  start-page: 342
  year: 2011
  end-page: 347
  ident: bib144
  article-title: Are statins diabetogenic?
  publication-title: Curr. Opin. Cardiol.
– volume: 376
  start-page: 1741
  year: 2010
  end-page: 1750
  ident: bib158
  article-title: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
  publication-title: Lancet (Lond. Engl.)
– volume: 85
  start-page: 19
  year: 2012
  end-page: 28
  ident: bib94
  article-title: Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis
  publication-title: Yale J. Biol. Med.
– volume: 42
  start-page: 677
  year: 2011
  end-page: 685
  ident: bib125
  article-title: Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls
  publication-title: Arch. Med. Res.
– volume: 3
  start-page: 1451
  year: 2010
  end-page: 1461
  ident: bib37
  article-title: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis
  publication-title: Cancer Prev. Res. (Phila. Pa.)
– volume: 23
  start-page: 143
  year: 2013
  end-page: 158
  ident: bib39
  article-title: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin
  publication-title: Cancer Cell
– volume: 17
  start-page: 412
  year: 2013
  end-page: 417
  ident: bib132
  article-title: Association of the C677T polymorphism in the MTHFR gene with hemorrhagic stroke: a meta-analysis
  publication-title: Genet. Test. Mol. Biomarker.
– volume: 65
  start-page: 2441
  year: 2005
  end-page: 2448
  ident: bib29
  article-title: Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype
  publication-title: Cancer Res.
– volume: 371
  start-page: 569
  year: 2008
  end-page: 578
  ident: bib72
  article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
  publication-title: Lancet (Lond. Engl.)
– volume: 7
  start-page: e36565
  year: 2012
  ident: bib103
  article-title: Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion
  publication-title: PLoS One
– volume: 32
  start-page: 1766
  year: 2012
  end-page: 1770
  ident: bib69
  article-title: Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 23
  start-page: 389
  year: 2009
  end-page: 400
  ident: bib134
  article-title: Statins, ACE inhibitors and ARBs in cardiovascular disease, Best practice & research
  publication-title: Clin. Endocrinol. Metab.
– volume: 8
  start-page: 1671
  year: 2009
  end-page: 1679
  ident: bib121
  article-title: Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells
  publication-title: Cancer Biol. Ther.
– volume: 8
  start-page: 9355
  year: 2015
  end-page: 9361
  ident: bib111
  article-title: Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis
  publication-title: Int. J. Clin. Exp. Med.
– volume: 58
  start-page: 1
  year: 2015
  end-page: 10
  ident: bib127
  article-title: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases
  publication-title: Eur. J. Med. Genet.
– volume: 330
  start-page: 1304
  year: 2005
  end-page: 1305
  ident: bib36
  article-title: Metformin and reduced risk of cancer in diabetic patients
  publication-title: BMJ (Clin. Res. Ed.)
– volume: 24
  start-page: 479
  year: 2004
  end-page: 487
  ident: bib28
  article-title: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase
  publication-title: J. Neurosci. Off. J. Soc. Neurosci.
– volume: 45
  start-page: 795
  year: 2013
  end-page: 802
  ident: bib140
  article-title: Statins: perspectives in cancer therapeutics
  publication-title: Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver
– volume: 574
  start-page: 63
  year: 2006
  end-page: 71
  ident: bib26
  article-title: AMPK and cell proliferation–AMPK as a therapeutic target for atherosclerosis and cancer
  publication-title: J. Physiol.
– volume: 13
  start-page: 746
  year: 2015
  end-page: 759
  ident: bib85
  article-title: Impaired LRP6-TCF7L2 activity enhances smooth muscle cell plasticity and causes coronary artery disease
  publication-title: Cell Rep.
– volume: 526
  start-page: 38
  year: 2002
  end-page: 42
  ident: bib31
  article-title: Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells
  publication-title: FEBS Lett.
– volume: 79
  start-page: 375
  year: 2008
  end-page: 392
  ident: bib133
  article-title: Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease
  publication-title: Vitam. Horm.
– volume: 23
  start-page: 9129
  year: 2004
  end-page: 9135
  ident: bib102
  article-title: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution
  publication-title: Oncogene
– volume: 463
  start-page: 612
  year: 2015
  end-page: 617
  ident: bib66
  article-title: Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 52
  start-page: 2013
  year: 2012
  end-page: 2037
  ident: bib17
  article-title: Emerging avenues linking inflammation and cancer
  publication-title: Free Radic. Biol. Med.
– volume: 6
  start-page: 352
  year: 2015
  end-page: 357
  ident: bib142
  article-title: Statin use and risk of diabetes mellitus
  publication-title: World J. Diabetes
– volume: 1138
  start-page: 65
  year: 2008
  end-page: 72
  ident: bib11
  article-title: Captopril as a potential inhibitor of lung tumor growth and metastasis
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 104
  start-page: 1470
  year: 2012
  end-page: 1484
  ident: bib70
  article-title: Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function
  publication-title: J. Natl. Cancer Inst.
– volume: 285
  start-page: 23398
  year: 2010
  end-page: 23409
  ident: bib60
  article-title: Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis
  publication-title: J. Biol. Chem.
– volume: 103
  start-page: 1280
  year: 2008
  end-page: 1288
  ident: bib93
  article-title: Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance
  publication-title: Circ. Res.
– volume: 14
  start-page: 8
  year: 2013
  ident: bib108
  article-title: Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population
  publication-title: BMC Med. Genet.
– volume: 210
  start-page: 221
  year: 1995
  end-page: 226
  ident: bib147
  article-title: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells
  publication-title: Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York N.Y.)
– volume: 23
  start-page: 348
  year: 2002
  end-page: 356
  ident: bib153
  article-title: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor
  publication-title: Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.
– volume: 94
  start-page: 1
  year: 2015
  end-page: 12
  ident: bib136
  article-title: HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?
  publication-title: Ann. Hematol.
– volume: 14
  start-page: 287
  year: 1995
  end-page: 301
  ident: bib117
  article-title: minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila
  publication-title: Neuron
– volume: 41
  start-page: 23
  year: 2006
  end-page: 34
  ident: bib52
  article-title: Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
  publication-title: Pediatr. Pulmonol.
– volume: 115
  start-page: 1210
  year: 2005
  end-page: 1220
  ident: bib90
  article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
  publication-title: J. Clin. Investig.
– volume: 315
  start-page: 1278
  year: 2007
  end-page: 1282
  ident: bib87
  article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors
  publication-title: Science
– volume: 49
  start-page: 711
  year: 2009
  end-page: 718
  ident: bib128
  article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis
  publication-title: J. Vasc. Surg.
– volume: 379
  start-page: 1602
  year: 2012
  end-page: 1612
  ident: bib10
  article-title: Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
  publication-title: Lancet (Lond. Engl.)
– volume: 52
  start-page: R51
  year: 2014
  end-page: R66
  ident: bib84
  article-title: A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose
  publication-title: J. Mol. Endocrinol.
– volume: 15
  start-page: 8
  year: 2006
  end-page: 13
  ident: bib150
  article-title: The tissue renin-angiotensin system and intracellular signalling
  publication-title: Curr. Opin. Nephrol. Hypertens.
– volume: 366
  start-page: 1279
  year: 2005
  end-page: 1289
  ident: bib55
  article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial
  publication-title: Lancet (Lond. Engl.)
– volume: 10
  start-page: 744
  year: 2010
  end-page: 755
  ident: bib23
  article-title: Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease
  publication-title: Curr. Mol. Med.
– volume: 6
  start-page: e17978
  year: 2011
  ident: bib107
  article-title: Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis
  publication-title: PLoS One
– volume: 30
  start-page: 1073
  year: 2009
  end-page: 1081
  ident: bib19
  article-title: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
  publication-title: Carcinogenesis
– volume: 38
  start-page: 865
  year: 2007
  end-page: 873
  ident: bib58
  article-title: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04)
  publication-title: Stroke
– volume: 93
  start-page: 5793
  year: 1996
  end-page: 5796
  ident: bib81
  article-title: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 29
  start-page: 152
  year: 2007
  end-page: 155
  ident: bib113
  article-title: Identification of new DNA markers of endometrial cancer in patients from the Ukrainian population
  publication-title: Exp. Oncol.
– volume: 67
  start-page: 2005
  year: 2004
  end-page: 2011
  ident: bib32
  article-title: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase
  publication-title: Biochem. Pharmacol.
– volume: 66
  start-page: 271
  year: 2015
  end-page: 278
  ident: bib43
  article-title: Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery
  publication-title: J. Cardiol.
– volume: 108
  start-page: 1914
  year: 2011
  end-page: 1918
  ident: bib86
  article-title: Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 130
  start-page: 543
  year: 1988
  end-page: 551
  ident: bib152
  article-title: Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study
  publication-title: Am. J. Pathol.
– volume: 88
  start-page: 1340
  year: 2008
  end-page: 1348
  ident: bib63
  article-title: Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer
  publication-title: Lab. Investig. J. Tech. Methods Pathol.
– volume: 115
  start-page: 2939
  year: 2007
  end-page: 2947
  ident: bib15
  article-title: Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development
  publication-title: Circulation
– volume: 21
  start-page: 188
  year: 2014
  end-page: 193
  ident: bib47
  article-title: The PPARgamma agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells
  publication-title: Cancer Gene Ther.
– volume: 22
  start-page: 181
  year: 2011
  end-page: 186
  ident: bib74
  article-title: Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects
  publication-title: Eur. Cytokine Netw.
– volume: 287
  start-page: 1335
  year: 2012
  end-page: 1344
  ident: bib96
  article-title: LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake
  publication-title: J. Biol. Chem.
– volume: 5
  start-page: 337
  year: 2014
  end-page: 347
  ident: bib119
  article-title: Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells
  publication-title: Genes & Cancer
– volume: 142
  start-page: 3125
  year: 2001
  end-page: 3134
  ident: bib44
  article-title: Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells
  publication-title: Endocrinology
– volume: 6
  start-page: 243
  year: 2006
  end-page: 255
  ident: bib151
  article-title: Manipulating the angiotensin system–new approaches to the treatment of solid tumours
  publication-title: Expert Opin. Biol. Ther.
– volume: 64
  start-page: 319
  year: 2014
  end-page: 327
  ident: bib155
  article-title: Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis
  publication-title: J. Am. Coll. Cardiol.
– volume: 25
  start-page: 342
  year: 2004
  end-page: 348
  ident: bib12
  article-title: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
  publication-title: Eur. Heart J.
– volume: 377
  start-page: 31
  year: 2011
  end-page: 41
  ident: bib159
  article-title: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
  publication-title: Lancet (Lond. Engl.)
– volume: 207
  start-page: 12
  year: 2006
  end-page: 22
  ident: bib79
  article-title: Leptin and cancer
  publication-title: J. Cell. Physiol.
– volume: 11
  start-page: 664
  year: 2014
  end-page: 670
  ident: bib160
  article-title: Exploring unknowns in cardiology, Nature reviews
  publication-title: Cardiology
– volume: 375
  start-page: 735
  year: 2010
  end-page: 742
  ident: bib143
  article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
  publication-title: Lancet (Lond. Engl.)
– volume: 136
  start-page: 1601
  year: 2009
  end-page: 1608
  ident: bib139
  article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes
  publication-title: Gastroenterology
– volume: 24
  start-page: 5389
  year: 2005
  end-page: 5395
  ident: bib64
  article-title: FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis
  publication-title: Oncogene
– volume: 227
  start-page: 216
  year: 2013
  end-page: 221
  ident: bib80
  article-title: Adipokines as mediators of endothelial function and atherosclerosis
  publication-title: Atherosclerosis
– volume: 22
  start-page: 17
  year: 2012
  end-page: 27
  ident: bib137
  article-title: Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk
  publication-title: Ann. Epidemiol.
– volume: 85
  start-page: 1
  year: 2015
  end-page: 10
  ident: bib25
  article-title: AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-kappaB/LOX-1 pathway
  publication-title: Vasc. Pharmacol.
– year: 2014
  ident: bib1
  publication-title: Global Status Report on Noncommunicable Diseases 2014
– volume: 75
  start-page: 528
  year: 2011
  end-page: 535
  ident: bib42
  article-title: Role of peroxisome proliferator-activated receptor-gamma in atherosclerosis: an update
  publication-title: Circ. J. Off. J. Jpn. Circ. Soc.
– volume: 321
  start-page: 161
  year: 2004
  end-page: 167
  ident: bib33
  article-title: AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 185
  start-page: 1274
  year: 2010
  end-page: 1282
  ident: bib89
  article-title: Wnt5a induces endothelial inflammation via beta-catenin-independent signaling
  publication-title: J. Immunol. (Baltim. Md. 1950)
– volume: 62
  start-page: 19
  year: 2012
  end-page: 27
  ident: bib49
  article-title: Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-gamma ligands via Wnt signaling pathway
  publication-title: Cell Biochem. Biophys.
– volume: 352
  start-page: 2184
  year: 2005
  end-page: 2192
  ident: bib138
  article-title: Statins and the risk of colorectal cancer
  publication-title: N. Engl. J. Med.
– volume: 16
  start-page: 293
  year: 2005
  end-page: 299
  ident: bib8
  article-title: Angiotensin receptors: a new role in cancer?
  publication-title: Trends Endocrinol. Metab. TEM
– volume: 125
  start-page: 885
  year: 2015
  end-page: 894
  ident: bib130
  article-title: Association between the methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and ischemic stroke in the Chinese population: a meta-analysis
  publication-title: Int. J. Neurosci.
– volume: 17
  start-page: 197
  year: 2013
  end-page: 209
  ident: bib97
  article-title: LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans
  publication-title: Cell Metab.
– volume: 204
  start-page: 996
  year: 2007
  end-page: 1005
  ident: bib146
  article-title: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma
  publication-title: J. Am. Coll. Surg.
– volume: 107
  start-page: 5136
  year: 2010
  end-page: 5141
  ident: bib104
  article-title: LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 345
  start-page: 164
  year: 2014
  end-page: 173
  ident: bib20
  article-title: Molecular mechanisms underlying chronic inflammation-associated cancers
  publication-title: Cancer Lett.
– volume: 85
  start-page: 777
  year: 2007
  end-page: 782
  ident: bib110
  article-title: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis
  publication-title: J. Mol. Med. (Berl. Ger.)
– volume: 56
  start-page: 2745
  year: 1996
  end-page: 2747
  ident: bib65
  article-title: Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells
  publication-title: Cancer Res.
– volume: 294
  start-page: H2864
  year: 2008
  end-page: H2870
  ident: bib88
  article-title: Wnt5a is expressed in murine and human atherosclerotic lesions
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
– volume: 18
  start-page: 1089
  year: 2014
  end-page: 1101
  ident: bib13
  article-title: NF-kappaB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links
  publication-title: Expert Opin. Ther. Targets
– volume: 287
  start-page: 7213
  year: 2012
  end-page: 7223
  ident: bib95
  article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure
  publication-title: J. Biol. Chem.
– volume: 34
  start-page: 1221
  year: 2013
  end-page: 1225
  ident: bib98
  article-title: Rare nonconservative LRP6 mutations are associated with metabolic syndrome
  publication-title: Hum. Mutat.
– volume: 6
  start-page: 268
  year: 2006
  ident: bib116
  article-title: Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
  publication-title: BMC Cancer
– volume: 379
  start-page: 1569
  year: 2012
  end-page: 1571
  ident: bib157
  article-title: Are we ready to recommend aspirin for cancer prevention?
  publication-title: Lancet (Lond. Engl.)
– volume: 57
  start-page: 278
  year: 2007
  end-page: 300
  ident: bib2
  article-title: Patient-reported outcomes in cancer: a review of recent research and policy initiatives
  publication-title: CA Cancer J. Clin.
– volume: 8
  start-page: 263
  year: 2011
  end-page: 275
  ident: bib78
  article-title: The multifactorial role of leptin in driving the breast cancer microenvironment, Nature reviews
  publication-title: Endocrinology
– volume: 4
  start-page: 221
  year: 2006
  end-page: 233
  ident: bib21
  article-title: Inflammation, a key event in cancer development
  publication-title: Mol. Cancer Res. MCR
– volume: 86
  start-page: 147
  year: 2015
  end-page: 157
  ident: bib141
  article-title: The role of DNA damage and repair in atherosclerosis: a review
  publication-title: J. Mol. Cell. Cardiol.
– volume: 450
  start-page: 494
  year: 2007
  end-page: 496
  ident: bib4
  article-title: Grand challenges in chronic non-communicable diseases
  publication-title: Nature
– volume: 31
  start-page: 905
  year: 2008
  end-page: 909
  ident: bib112
  article-title: Variation in TCF7L2 and increased risk of colon cancer: the Aherosclerosis Risk in Communities (ARIC) Study
  publication-title: Diabetes Care
– volume: 36
  start-page: 211
  year: 2013
  end-page: 215
  ident: bib77
  article-title: Effect of diet-induced weight loss on inflammatory cytokines in obese women
  publication-title: J. Endocrinol. Investig.
– volume: 323
  start-page: 40
  year: 2012
  end-page: 45
  ident: bib131
  article-title: Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis
  publication-title: J. Neurol. Sci.
– volume: 85
  start-page: 1
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib25
  article-title: AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-kappaB/LOX-1 pathway
  publication-title: Vasc. Pharmacol.
  doi: 10.1016/j.vph.2015.08.012
– volume: 1138
  start-page: 65
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib11
  article-title: Captopril as a potential inhibitor of lung tumor growth and metastasis
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1196/annals.1414.011
– volume: 7
  start-page: e36565
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib103
  article-title: Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036565
– volume: 107
  start-page: 5136
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib104
  article-title: LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0911220107
– volume: 42
  start-page: 677
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib125
  article-title: Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls
  publication-title: Arch. Med. Res.
  doi: 10.1016/j.arcmed.2011.11.009
– volume: 368
  start-page: 204
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib154
  article-title: Aspirin in the secondary prevention of cardiovascular disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1213380
– volume: 6
  start-page: 352
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib142
  article-title: Statin use and risk of diabetes mellitus
  publication-title: World J. Diabetes
  doi: 10.4239/wjd.v6.i2.352
– volume: 370
  start-page: 1909
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib122
  article-title: A form of the metabolic syndrome associated with mutations in DYRK1B
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1301824
– volume: 352
  start-page: 2184
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib138
  article-title: Statins and the risk of colorectal cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa043792
– volume: 15
  start-page: 170
  year: 2016
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib59
  article-title: Cardiovascular safety of type 2 diabetes medications: review of existing literature and clinical implications
  publication-title: Horm. (Athens, Greece)
  doi: 10.14310/horm.2002.1671
– volume: 93
  start-page: 5793
  year: 1996
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib81
  article-title: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.93.12.5793
– volume: 37
  start-page: 568
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib129
  article-title: Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis
  publication-title: Neurol. Res.
  doi: 10.1179/1743132815Y.0000000008
– volume: 14
  start-page: 5560
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib120
  article-title: Mirk/dyrk1B kinase in ovarian cancer
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms14035560
– volume: 130
  start-page: 543
  year: 1988
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib152
  article-title: Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study
  publication-title: Am. J. Pathol.
– volume: 227
  start-page: 216
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib80
  article-title: Adipokines as mediators of endothelial function and atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2012.12.029
– volume: 20
  start-page: 7137
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib45
  article-title: Emerging role of the beta-catenin-PPARgamma axis in the pathogenesis of colorectal cancer
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v20.i23.7137
– volume: 35
  start-page: 566
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib76
  article-title: Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women
  publication-title: J. Endocrinol. Investig.
– volume: 8
  start-page: 9355
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib111
  article-title: Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis
  publication-title: Int. J. Clin. Exp. Med.
– volume: 357
  start-page: 539
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib16
  article-title: Inflammation and cancer: back to Virchow?
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(00)04046-0
– volume: 15
  start-page: 8
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib150
  article-title: The tissue renin-angiotensin system and intracellular signalling
  publication-title: Curr. Opin. Nephrol. Hypertens.
  doi: 10.1097/01.mnh.0000196146.65330.ea
– volume: 49
  start-page: 1772
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib56
  article-title: The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2006.12.048
– volume: 115
  start-page: 1210
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib90
  article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI24140
– volume: 12
  start-page: 159
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib50
  article-title: The insulin and insulin-like growth factor receptor family in neoplasia: an update
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3215
– volume: 108
  start-page: 1914
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib86
  article-title: Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1019443108
– volume: 38
  start-page: 865
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib58
  article-title: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04)
  publication-title: Stroke
  doi: 10.1161/01.STR.0000257974.06317.49
– volume: 273
  start-page: 219
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib73
  article-title: Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
  publication-title: J. Intern. Med.
  doi: 10.1111/joim.12012
– volume: 6
  start-page: 268
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib116
  article-title: Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-6-268
– volume: 364
  start-page: 937
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib71
  article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(04)17018-9
– volume: 49
  start-page: 711
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib128
  article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis
  publication-title: J. Vasc. Surg.
  doi: 10.1016/j.jvs.2008.10.004
– volume: 31
  start-page: 905
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib112
  article-title: Variation in TCF7L2 and increased risk of colon cancer: the Aherosclerosis Risk in Communities (ARIC) Study
  publication-title: Diabetes Care
  doi: 10.2337/dc07-2131
– volume: 321
  start-page: 161
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib33
  article-title: AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2004.06.133
– volume: 34
  start-page: 1706
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib61
  article-title: Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-alpha
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2014.1942
– volume: 14
  start-page: 287
  year: 1995
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib117
  article-title: minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila
  publication-title: Neuron
  doi: 10.1016/0896-6273(95)90286-4
– volume: 103
  start-page: 1280
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib93
  article-title: Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.108.183863
– volume: 5
  start-page: 11000
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib100
  article-title: Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2769
– volume: 14
  start-page: 8
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib108
  article-title: Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population
  publication-title: BMC Med. Genet.
  doi: 10.1186/1471-2350-14-8
– volume: 330
  start-page: 1304
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib36
  article-title: Metformin and reduced risk of cancer in diabetic patients
  publication-title: BMJ (Clin. Res. Ed.)
  doi: 10.1136/bmj.38415.708634.F7
– volume: 13
  start-page: 746
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib85
  article-title: Impaired LRP6-TCF7L2 activity enhances smooth muscle cell plasticity and causes coronary artery disease
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.09.028
– volume: 65
  start-page: 2441
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib29
  article-title: Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-3025
– volume: 13
  start-page: 376
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib27
  article-title: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2011.03.009
– volume: 67
  start-page: 2005
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib32
  article-title: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2004.01.020
– volume: 57
  start-page: 278
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib2
  article-title: Patient-reported outcomes in cancer: a review of recent research and policy initiatives
  publication-title: CA Cancer J. Clin.
– volume: 29
  start-page: 539
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib105
  article-title: Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis
  publication-title: Oncogene
  doi: 10.1038/onc.2009.339
– volume: 24
  start-page: 479
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib28
  article-title: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase
  publication-title: J. Neurosci. Off. J. Soc. Neurosci.
  doi: 10.1523/JNEUROSCI.4288-03.2004
– volume: 185
  start-page: 1274
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib89
  article-title: Wnt5a induces endothelial inflammation via beta-catenin-independent signaling
  publication-title: J. Immunol. (Baltim. Md. 1950)
  doi: 10.4049/jimmunol.1000181
– volume: 196
  start-page: 55
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib34
  article-title: AMP-activated protein kinase and cancer
  publication-title: Acta Physiol. (Oxf. Engl.)
  doi: 10.1111/j.1748-1716.2009.01980.x
– volume: 287
  start-page: 1335
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib96
  article-title: LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.295287
– volume: 463
  start-page: 612
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib66
  article-title: Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.05.108
– volume: 375
  start-page: 735
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib143
  article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(09)61965-6
– volume: 61
  start-page: 846
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib123
  article-title: Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis
  publication-title: Metab. Clin. Exp.
  doi: 10.1016/j.metabol.2011.10.013
– volume: 373
  start-page: 1849
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib156
  article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(09)60503-1
– volume: 4
  start-page: 221
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib21
  article-title: Inflammation, a key event in cancer development
  publication-title: Mol. Cancer Res. MCR
  doi: 10.1158/1541-7786.MCR-05-0261
– volume: 2012
  start-page: 968040
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib46
  article-title: Targeting PPARgamma signaling cascade for the prevention and treatment of prostate cancer
  publication-title: PPAR Res.
  doi: 10.1155/2012/968040
– volume: 285
  start-page: 23398
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib60
  article-title: Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.100321
– volume: 23
  start-page: 348
  year: 2002
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib153
  article-title: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor
  publication-title: Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.
  doi: 10.1159/000069792
– volume: 34
  start-page: 1221
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib98
  article-title: Rare nonconservative LRP6 mutations are associated with metabolic syndrome
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.22360
– volume: 10
  start-page: 15
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib109
  article-title: Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis
  publication-title: BMC Med. Genet.
  doi: 10.1186/1471-2350-10-15
– volume: 315
  start-page: 1278
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib87
  article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors
  publication-title: Science
  doi: 10.1126/science.1136370
– volume: 18
  start-page: 1089
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib13
  article-title: NF-kappaB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1517/14728222.2014.938051
– volume: 17
  start-page: 9
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib83
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2009.06.016
– volume: 210
  start-page: 221
  year: 1995
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib147
  article-title: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells
  publication-title: Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York N.Y.)
  doi: 10.3181/00379727-210-43942
– volume: 62
  start-page: 19
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib49
  article-title: Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-gamma ligands via Wnt signaling pathway
  publication-title: Cell Biochem. Biophys.
  doi: 10.1007/s12013-011-9253-x
– volume: 12
  start-page: 1782
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib67
  article-title: Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease
  publication-title: Curr. Drug Targets
  doi: 10.2174/138945011797635803
– volume: 376
  start-page: 1741
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib158
  article-title: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(10)61543-7
– volume: 450
  start-page: 494
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib4
  article-title: Grand challenges in chronic non-communicable diseases
  publication-title: Nature
  doi: 10.1038/450494a
– volume: 278
  start-page: 31629
  year: 2003
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib22
  article-title: Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M212831200
– volume: 48
  start-page: e224
  year: 2016
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib35
  article-title: AMPK activators: mechanisms of action and physiological activities
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2016.16
– volume: 195
  start-page: e69
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib14
  article-title: HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.05.026
– volume: 115
  start-page: 2939
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib15
  article-title: Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.696922
– volume: 51
  start-page: 91
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib53
  article-title: Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
  publication-title: Acta Diabetol.
  doi: 10.1007/s00592-013-0504-8
– volume: 157
  start-page: 291
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib68
  article-title: PAI-1, progress in understanding the clinical problem and its aetiology
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.2012.09074.x
– volume: 32
  start-page: 1766
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib69
  article-title: Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.111.241927
– year: 2002
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib5
– volume: 8
  start-page: 263
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib78
  article-title: The multifactorial role of leptin in driving the breast cancer microenvironment, Nature reviews
  publication-title: Endocrinology
– volume: 29
  start-page: 152
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib113
  article-title: Identification of new DNA markers of endometrial cancer in patients from the Ukrainian population
  publication-title: Exp. Oncol.
– volume: 94
  start-page: 1
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib136
  article-title: HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-014-2236-4
– volume: 23
  start-page: 143
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib39
  article-title: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.12.008
– volume: 136
  start-page: 1601
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib139
  article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.01.053
– volume: 352
  start-page: 179
  year: 1998
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib145
  article-title: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(98)03228-0
– volume: 75
  start-page: 528
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib42
  article-title: Role of peroxisome proliferator-activated receptor-gamma in atherosclerosis: an update
  publication-title: Circ. J. Off. J. Jpn. Circ. Soc.
– volume: 88
  start-page: 1340
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib63
  article-title: Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer
  publication-title: Lab. Investig. J. Tech. Methods Pathol.
  doi: 10.1038/labinvest.2008.97
– volume: 207
  start-page: 12
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib79
  article-title: Leptin and cancer
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.20472
– volume: 10
  start-page: 744
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib23
  article-title: Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease
  publication-title: Curr. Mol. Med.
  doi: 10.2174/156652410793384187
– volume: 17
  start-page: 197
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib97
  article-title: LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2013.01.009
– volume: 23
  start-page: 389
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib134
  article-title: Statins, ACE inhibitors and ARBs in cardiovascular disease, Best practice & research
  publication-title: Clin. Endocrinol. Metab.
– volume: 22
  start-page: 17
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib137
  article-title: Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk
  publication-title: Ann. Epidemiol.
  doi: 10.1016/j.annepidem.2011.10.006
– volume: 56
  start-page: 2745
  year: 1996
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib65
  article-title: Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells
  publication-title: Cancer Res.
– volume: 379
  start-page: 1569
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib157
  article-title: Are we ready to recommend aspirin for cancer prevention?
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(11)61654-1
– volume: 21
  start-page: 372
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib40
  article-title: Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.21.3.372
– volume: 19
  start-page: 554
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib135
  article-title: Pleiotropic effects of statins
  publication-title: Indian J. Endocrinol. Metab.
  doi: 10.4103/2230-8210.163106
– volume: 16
  start-page: 293
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib8
  article-title: Angiotensin receptors: a new role in cancer?
  publication-title: Trends Endocrinol. Metab. TEM
  doi: 10.1016/j.tem.2005.07.009
– volume: 768
  start-page: 217
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib51
  article-title: Effects of Thiazolidinediones on metabolism and cancer: relative influence of PPARgamma and IGF-1 signaling
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2015.10.057
– volume: 44
  start-page: 114
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib75
  article-title: Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery
  publication-title: Endocrine
  doi: 10.1007/s12020-012-9821-x
– volume: 287
  start-page: 7213
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib95
  article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.286724
– volume: 131
  start-page: 242
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib24
  article-title: AMPK and vasculoprotection
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2010.11.002
– volume: 366
  start-page: 1279
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib55
  article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(05)67528-9
– volume: 371
  start-page: 569
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib72
  article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(08)60269-X
– volume: 22
  start-page: 181
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib74
  article-title: Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects
  publication-title: Eur. Cytokine Netw.
  doi: 10.1684/ecn.2011.0295
– volume: 81
  start-page: 761
  year: 1999
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib148
  article-title: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
  publication-title: Int. J. Cancer J. Int. du Cancer
  doi: 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1
– volume: 64
  start-page: 319
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib155
  article-title: Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2014.03.049
– volume: 104
  start-page: 1470
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib70
  article-title: Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djs377
– volume: 5
  start-page: 337
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib119
  article-title: Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells
  publication-title: Genes & Cancer
  doi: 10.18632/genesandcancer.29
– volume: 58
  start-page: 1
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib127
  article-title: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases
  publication-title: Eur. J. Med. Genet.
  doi: 10.1016/j.ejmg.2014.10.004
– volume: 23
  start-page: 628
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib91
  article-title: Wnt signaling in cardiovascular physiology
  publication-title: Trends Endocrinol. Metab. TEM
  doi: 10.1016/j.tem.2012.06.001
– volume: 86
  start-page: 147
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib141
  article-title: The role of DNA damage and repair in atherosclerosis: a review
  publication-title: J. Mol. Cell. Cardiol.
  doi: 10.1016/j.yjmcc.2015.07.005
– volume: 6
  start-page: 243
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib151
  article-title: Manipulating the angiotensin system–new approaches to the treatment of solid tumours
  publication-title: Expert Opin. Biol. Ther.
  doi: 10.1517/14712598.6.3.243
– volume: 345
  start-page: 164
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib20
  article-title: Molecular mechanisms underlying chronic inflammation-associated cancers
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2013.08.014
– volume: 142
  start-page: 3125
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib44
  article-title: Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells
  publication-title: Endocrinology
  doi: 10.1210/endo.142.7.8272
– volume: 45
  start-page: 795
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib140
  article-title: Statins: perspectives in cancer therapeutics
  publication-title: Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver
– volume: 26
  start-page: 342
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib144
  article-title: Are statins diabetogenic?
  publication-title: Curr. Opin. Cardiol.
  doi: 10.1097/HCO.0b013e3283470359
– volume: 377
  start-page: 31
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib159
  article-title: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(10)62110-1
– volume: 52
  start-page: 2013
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib17
  article-title: Emerging avenues linking inflammation and cancer
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2012.02.035
– volume: 21
  start-page: 188
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib47
  article-title: The PPARgamma agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells
  publication-title: Cancer Gene Ther.
  doi: 10.1038/cgt.2014.16
– volume: 11
  start-page: 265
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib3
  article-title: Depression and health-related quality of life in people with coronary heart disease: a systematic review
  publication-title: Eur. J. Cardiovasc. Nurs.
  doi: 10.1177/1474515111430928
– volume: 85
  start-page: 777
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib110
  article-title: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis
  publication-title: J. Mol. Med. (Berl. Ger.)
  doi: 10.1007/s00109-007-0203-4
– volume: 24
  start-page: 5389
  year: 2005
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib64
  article-title: FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208555
– volume: 174
  start-page: 2007
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib41
  article-title: Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2009.080611
– volume: 41
  start-page: 23
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib52
  article-title: Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
  publication-title: Pediatr. Pulmonol.
  doi: 10.1002/ppul.20338
– volume: 565
  start-page: 39
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib124
  article-title: Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis
  publication-title: Gene
  doi: 10.1016/j.gene.2015.03.062
– volume: 79
  start-page: 375
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib133
  article-title: Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease
  publication-title: Vitam. Horm.
  doi: 10.1016/S0083-6729(08)00413-5
– volume: 347
  start-page: 109
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib7
  article-title: Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2006.06.082
– volume: 30
  start-page: 1073
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib19
  article-title: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgp127
– volume: 24
  start-page: 827
  year: 2003
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib30
  article-title: AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgg032
– volume: 526
  start-page: 38
  year: 2002
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib31
  article-title: Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(02)03110-1
– volume: 202
  start-page: 521
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib54
  article-title: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.05.029
– volume: 25
  start-page: 4363
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib62
  article-title: Progress in the development of fatty acid synthase inhibitors as anticancer targets
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2015.08.087
– volume: 276
  start-page: 39819
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib118
  article-title: Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104091200
– volume: 121
  start-page: 2373
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib18
  article-title: Inflammation and cancer: an ancient link with novel potentials
  publication-title: Int. J. Cancer. J. Int. du Cancer
  doi: 10.1002/ijc.23173
– volume: 204
  start-page: 996
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib146
  article-title: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma
  publication-title: J. Am. Coll. Surg.
  doi: 10.1016/j.jamcollsurg.2007.01.067
– year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib1
– volume: 11
  start-page: 664
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib160
  article-title: Exploring unknowns in cardiology, Nature reviews
  publication-title: Cardiology
– volume: 21
  start-page: 967
  year: 2000
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib126
  article-title: Homocysteine and atherothrombosis–mechanisms for injury
  publication-title: Eur. Heart J.
  doi: 10.1053/euhj.1999.1914
– volume: 323
  start-page: 40
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib131
  article-title: Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2012.07.038
– volume: 34
  start-page: 4914
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib106
  article-title: Oncogenic KRAS signalling promotes the Wnt/beta-catenin pathway through LRP6 in colorectal cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2014.416
– volume: 2
  start-page: 385
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib149
  article-title: Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer
  publication-title: Curr. Vasc. Pharmacol.
  doi: 10.2174/1570161043385556
– volume: 154
  start-page: 664
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib92
  article-title: Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling
  publication-title: Cell
  doi: 10.1016/j.cell.2013.06.030
– volume: 136
  start-page: 593
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib114
  article-title: Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-012-2299-7
– volume: 6
  start-page: e17978
  year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib107
  article-title: Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0017978
– volume: 125
  start-page: 885
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib130
  article-title: Association between the methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and ischemic stroke in the Chinese population: a meta-analysis
  publication-title: Int. J. Neurosci.
  doi: 10.3109/00207454.2014.984295
– volume: 29
  start-page: 3436
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib101
  article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a
  publication-title: FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol.
– volume: 2008
  start-page: 431763
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib82
  article-title: Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancer
  publication-title: PPAR Res.
  doi: 10.1155/2008/431763
– volume: 8
  start-page: 1671
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib121
  article-title: Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.8.17.9322
– volume: 19
  start-page: 209
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib99
  article-title: The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2013.11.023
– volume: 66
  start-page: 271
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib43
  article-title: Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery
  publication-title: J. Cardiol.
  doi: 10.1016/j.jjcc.2015.05.004
– year: 2011
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib6
– volume: 379
  start-page: 1602
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib10
  article-title: Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
  publication-title: Lancet (Lond. Engl.)
  doi: 10.1016/S0140-6736(11)61720-0
– volume: 294
  start-page: H2864
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib88
  article-title: Wnt5a is expressed in murine and human atherosclerotic lesions
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.00982.2007
– volume: 52
  start-page: R51
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib84
  article-title: A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose
  publication-title: J. Mol. Endocrinol.
  doi: 10.1530/JME-13-0152
– volume: 574
  start-page: 63
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib26
  article-title: AMPK and cell proliferation–AMPK as a therapeutic target for atherosclerosis and cancer
  publication-title: J. Physiol.
  doi: 10.1113/jphysiol.2006.108324
– volume: 3
  start-page: 1451
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib37
  article-title: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis
  publication-title: Cancer Prev. Res. (Phila. Pa.)
  doi: 10.1158/1940-6207.CAPR-10-0157
– volume: 108
  start-page: 881
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib38
  article-title: Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis
  publication-title: Am. J. Gastroenterol.
  doi: 10.1038/ajg.2013.5
– volume: 23
  start-page: 9129
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib102
  article-title: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208123
– volume: 25
  start-page: 342
  year: 2004
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib12
  article-title: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
  publication-title: Eur. Heart J.
  doi: 10.1016/j.ehj.2003.12.007
– volume: 23
  start-page: 221
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib9
  article-title: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
  publication-title: Cancer Causes Control CCC
– volume: 298
  start-page: 1180
  year: 2007
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib57
  article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials
  publication-title: Jama
  doi: 10.1001/jama.298.10.1180
– volume: 12
  start-page: 243
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib115
  article-title: Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.10953
– volume: 36
  start-page: 211
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib77
  article-title: Effect of diet-induced weight loss on inflammatory cytokines in obese women
  publication-title: J. Endocrinol. Investig.
– volume: 22
  start-page: 2215
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib48
  article-title: Minireview: nuclear receptors and breast cancer
  publication-title: Mol. Endocrinol. (Baltim. Md.)
  doi: 10.1210/me.2007-0421
– volume: 17
  start-page: 412
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib132
  article-title: Association of the C677T polymorphism in the MTHFR gene with hemorrhagic stroke: a meta-analysis
  publication-title: Genet. Test. Mol. Biomarker.
  doi: 10.1089/gtmb.2012.0295
– volume: 85
  start-page: 19
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.06.001_bib94
  article-title: Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis
  publication-title: Yale J. Biol. Med.
SSID ssj0004718
Score 2.557175
SecondaryResourceType review_article
Snippet Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are...
Abstract Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 343
SubjectTerms Animals
Anticarcinogenic Agents - therapeutic use
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cardiovascular
Cardiovascular Agents - therapeutic use
Cardiovascular Diseases - genetics
Cardiovascular Diseases - metabolism
Cardiovascular Diseases - pathology
Cardiovascular Diseases - prevention & control
Cardiovascular System - drug effects
Cardiovascular System - metabolism
Cardiovascular System - pathology
Cell Transformation, Neoplastic - drug effects
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Cell Transformation, Neoplastic - pathology
Gene Expression Regulation, Neoplastic
Humans
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - prevention & control
Risk Factors
Signal Transduction - drug effects
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dT9sw8ARFgr1MbOyj40OeNB4L2EkdB00TqAJ1TPAEEm-WayciqEoj0grx73fXOCmlIIF4aZom5zR35_vwfRjgF5exIFeiYw36JuEAvw1Q83SMVAOcWrTsQEsD5xeyfxWeXXevl6BX18JQWqWX_ZVMn0pr_8u-x-Z-kWVU44uzDe0ZjkwqQhUuw4oIYi5asHL891__YlYeGfFKIFM2AgKswu4szWtqZ41KHBU_M2rgzaO9KkLxkqpaNEUXMyrXJnlhHu7NcPhIXZ2uw0dvZ7Lj6lU-wVKSf4bVcx9J3wDXm0tEZT5Qw0zumCVOuDtk9Y6jDA1bVt5QqnpzH-1kfG8eyilAMet_nVlW-K5Qo_wLXJ2eXPb6Hb_jQsdKLsdIMIf6O1XWpd00FdYkqbWxchH5VTaUFo0PhUejnItkbCRab64rKJYautQFwVdo5aM8-Q5MILVVrIwL0oR8VBM4ZAvXpYUrqzhvw-8audr6duS0K8ZQ13lnt_oJbTTRRld5eG2QDXhR9eV4LeCfmpK6Lj5FcalRg7x2gOi5AZLST_5Sc10KfaAXGLQNRw3kHI-_5eE_a-bTKAcouGPyZDTBh5LWihXivA3fKmZsECOoCghdAfzrc2za3EA9xuev5NnNtNe4FAcosQVCNgz9Nnz_eP9Lb8IHOqvSLregNb6bJNtoCo4HO36q_wdRIWOs
  priority: 102
  providerName: Elsevier
Title Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021915017302484
https://www.clinicalkey.es/playcontent/1-s2.0-S0021915017302484
https://dx.doi.org/10.1016/j.atherosclerosis.2017.06.001
https://www.ncbi.nlm.nih.gov/pubmed/28624099
https://www.proquest.com/docview/1911198889
https://pubmed.ncbi.nlm.nih.gov/PMC6207942
https://www.ncbi.nlm.nih.gov/pmc/articles/6207942
UnpaywallVersion submittedVersion
Volume 263
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 1879-1484
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 1879-1484
  databaseCode: ACRLP
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 1879-1484
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 1879-1484
  databaseCode: AIKHN
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 1879-1484
  databaseCode: AKRWK
  dateStart: 19700101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NVhq88D0oH1WQ4DHZnCaugxCimpgKaBVCVBpPlmMnWqFLo6XVNB7427mLnYxuIK28tI2Scxr75_Od75c7gJeMJyG5Er5W6JtEKf5KceXxFRcpTi3adqCtgcMJH0-jj0fx0Raw5l2YmrSv01lQzE-CYnZccyvLE73b8MR2ebiHGEKt2-UxOswd6E4nn0ffLJWD4eStq7JSEW0fTf1oG15dcLpqo2pRYTv4OaNs3WwY2HDEv9alq3bnVfrkzVVRqvMzNZ__sTYd3IEvzVNZSsqPYLVMA_3zUsLHjR77Ltx2lqo3sqfuwVZW3IftQxeLfwBmf43K6rlQj6cK42nC0ulrr6lZ6qFp7FXHRHZvr6NayGfqvKoFyosM2jPtlS6v1KJ4CNOD91_3x76r2eBrzvgSh9ygBZALbfI4z0OtslzrRJgheWY64hrNF4HfShgz5IniaP-ZOKRobGRyMxjsQKdYFNlj8ELEi0iEMoM8Iy9XDQwCy8S09aUFYz1404yY1C6hOdXVmMuGufZdXhpwSQMuLZOvB7wVL21mj-sKvm3gIZvXV1HhSlyDrtvA8G8NZJVTH5VksgrlnqRIOiNAM9TDIYK5B-9aSWchWctnk5u_aBAtUZNQeEgV2WKFN6V1LxHY5z14ZBHedkxI7xGhM4F_fQ377QWUpXz9DKK4zlbugIuS7SzZrL-f_LfkU7hFR5av-Qw6y9NV9hxtyGXahxvBL9aH7ujDp_Gk73TIbw6wej0
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dT9sw8MSKBLwgNrZRPjZPYo8dxEkcB6EJVA2VQfsEEm-WayciU5VGpBXi33PXOOm6bhJoL02V5Jzk7nwfvg8DHHoi5uRKdIxG3yQY4r8hap6OFnKIU4uWHWhpoD8Qvdvg5114twLduhaG0iqd7K9k-kxauzNHDptHRZZRjS_ONrRnPGRSHsjgDawGoR_LFqyeX171BvPyyMirBDJlIyDAGnydp3nN7KxxiaPib0YNvL3oWxWh-JeqWjZFlzMq16d5oZ8e9Wj0m7q62IJNZ2ey8-pT3sJKkr-Dtb6LpG-D7S4kojIXqGE6t8wQJzycsHrHUYaGLSvvKVW9uY92Mn7UT-UMoJj3v84MK1xXqHH-Hm4vftx0ex2340LHCE9MkGAW9XcqjU3DNOVGJ6kxsbQR-VUmEAaND4lHLa2NRKwFWm825BRLDWxqff8DtPJxnuwA40htGUtt_TQhH1X7FtnChrRwZaTnteG0Rq4yrh057YoxUnXe2S_1B20U0UZVeXhtEA14UfXleCng95qSqi4-RXGpUIO8dIDobwMkpZv8pfJUydWxWmLQNpw1kAs8_pqHf6mZT6EcoOCOzpPxFB9KWiuWiPM2fKyYsUEMpyogdAXw1RfYtLmBeowvXsmz-1mvccGPUWJzhGwY-nX43v3_j_4M672b_rW6vhxc7cEGXalSMPehNXmYJgdoFk6Gn9y0fwZNPGai
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED9KCt1e9v2RfaHB9mi3cmxFHmOslJUyaBljge5JyJJNs6WKqRNK99fvzpbcpd2g2UsSY58cSz-d7nQ_3wG84SJPyJWIjEbfJC3wV4ErT6SFLHBq0bYDbQ0cHomDSfr5ODveAB7ehWlJ-6aYxm52GrvpScutrE_NduCJbYtkBzGEWndTZOgwD2BzcvRl93tH5eA4eduqrFREO0JTP92Ct5ecrtaomjfYDn5OKVs3H8ddOOJf69J1u_M6ffLW0tX64lzPZn-sTft34Wt4qo6S8jNeLorY_LqS8HGtx74Hd7ylyna7U_dho3QPYOvQx-Ifgt1bobIyH-ph2llmCEtn71ioWcrQNGbNCZHd--uoFvK5vmhagfoyg_bUsNrnlZq7RzDZ__Rt7yDyNRsiI7hY4JBbtAAqaWyVVVVidFkZk0s7Js_MpMKg-SLxW0trxyLXAu0_myUUjU1tZUejxzBwc1c-BZYgXmQutR1VJXm5emQRWDajrS8jOR_C-zBiyviE5lRXY6YCc-2HujLgigZcdUy-IYhevO4ye9xU8EOAhwqvr6LCVbgG3bSB8d8aKBuvPhrFVZOoHUWRdE6A5qiHEwTzED72kt5C6iyfdW7-OiBaoSah8JB25XyJN6V1L5fY50N40iG875iE3iNCZwL_-gr2-wsoS_nqGURxm63cAxcl-1myXn8_-2_J53Cbjjq-5gsYLM6W5Uu0IRfFK681fgN2PHex
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiovascular+disease+and+cancer%3A+Evidence+for+shared+disease+pathways+and+pharmacologic+prevention&rft.jtitle=Atherosclerosis&rft.au=Masoudkabir%2C+Farzad&rft.au=Sarrafzadegan%2C+Nizal&rft.au=Gotay%2C+Carolyn&rft.au=Ignaszewski%2C+Andrew&rft.date=2017-08-01&rft.issn=1879-1484&rft.eissn=1879-1484&rft.volume=263&rft.spage=343&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2017.06.001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon